Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

NCT02540161 is registered in ClinicalTrials.gov with Annick Desjardins as lead sponsor.

NCT NCT02540161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02540161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma
Lead sponsor
Annick Desjardins
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2016
Completion date
April 27, 2020
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant glioma